Article Versions Notes

Di Giacomo D, Di Domenico M, Defourny SVP, Malatesta D, Di Teodoro G, Martino M, Viola A, D’Alterio N, Cammà C, Modesto P, et al. Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors. Life. 2022; 12(6):851. https://doi.org/10.3390/life12060851

Di Giacomo, Daniela, Marco Di Domenico, Sabrina Vanessa Patrizia Defourny, Daniela Malatesta, Giovanni Di Teodoro, Michele Martino, Antonello Viola, Nicola D’Alterio, Cesare Cammà, Paola Modesto, and et al. 2022. "Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors" Life 12, no. 6: 851. https://doi.org/10.3390/life12060851

Di Giacomo, D., Di Domenico, M., Defourny, S. V. P., Malatesta, D., Di Teodoro, G., Martino, M., Viola, A., D’Alterio, N., Cammà, C., Modesto, P., & Petrini, A. (2022). Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors. Life, 12(6), 851. https://doi.org/10.3390/life12060851